Results 91 to 100 of about 5,907 (256)
Phylogenetic tree of NBDs1 from subfamily ABCC.
Red, C. populi (Cp); blue, H. sapiens (Hs); black, T. castaneum (Tc). HsABC8 and 9 are sulfonylurea receptors (SUR); *, T. castanaeum with phenotype after RNAi. Numbers at nodes represent bootstrap values.
Ding Wang (191462) +6 more
core +1 more source
ABSTRACT Aims To assess contemporary UK trends in second‐line treatment initiations and outcomes across age‐and‐frailty groups in people with type 2 diabetes (T2D). Materials and Methods We studied 117 046 UK adults with T2D initiating second‐line therapy between 2019–2024 (Clinical Practice Research Datalink).
M. M. Dinsdale +11 more
wiley +1 more source
Erythrocyte Insulin Receptors in Non-Insulin-Dependent Diabetics before and after Treatment [PDF]
On 40 non-insulin-dependent diabetes mellitus (NIDDM) patients who were hospitalized for the purpose of control and education of diabetes mellitus, erythrocyte insulin receptor assay was conducted with the used of 126l-insulin at the time of admission ...
TANGGO, Yunus
core
Patterns and Trends of Glucose‐Lowering Therapy in Alzheimer's Disease and Related Dementias
Diabetes, Obesity and Metabolism, EarlyView.
Huilin Tang +7 more
wiley +1 more source
ABSTRACT Objective Soluble receptor for advanced glycation end‐products (sRAGE) and soluble Toll‐like receptor 4 (sTLR4) are circulating pattern recognition receptor isoforms implicated in inflammatory regulation in type 2 diabetes mellitus (T2DM). This study examined the effects of supervised aerobic exercise training (AET) on circulating sRAGE, sTLR4,
Ryan K. Perkins +9 more
wiley +1 more source
ABSTRACT Aims Obesity affects over 800 million people globally and is associated with complications including cardiovascular disease and type 2 diabetes (T2D). Early response to weight loss interventions may help optimize achievement of individual treatment goals.
Alexander Kokkinos +7 more
wiley +1 more source
ABSTRACT Introduction Administration of a somatostatin receptor 2 antagonist (SSTR2a) increases glucagon responsiveness to hypoglycaemia in insulin‐treated type 2 diabetes (T2D), but the durability of this effect and the impact of repeated SSTR2a dosing on overall glycaemia in T2D are unclear.
Ninoschka C. D'Souza +7 more
wiley +1 more source
Ashcroft, S, Ashcroft, F
openaire +2 more sources
Intracellular application of the sulfonylurea tolbutamide during whole-cell patch-clamp recordings stimulated exocytosis >5-fold when applied at a cytoplasmic Ca2+ concentration of 0.17 microM.
Berggren, PO +24 more
core +1 more source
Prescribing Trajectories in Type 2 Diabetes in the United States, 2019–2024
ABSTRACT Importance Clinical guidelines for type 2 diabetes (T2D) provide population‐level recommendations, but real‐world treatment patterns evolve dynamically and vary across patients. Understanding longitudinal prescribing trajectories may reveal heterogeneity in care not captured by cross‐sectional analyses.
Tobias S. Lux +14 more
wiley +1 more source

